medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2014, Número 5

<< Anterior Siguiente >>

Ann Hepatol 2014; 13 (5)


Antimitochondrial antibody serocoversion post-liver transplant during hepatitis C treatment with peginterferon α, ribavirin and telaprevir

Marquez-Azalgara V, Hussaini T, Erb SR, Yoshida EM

Idioma: Ingles.
Referencias bibliográficas: 9
Paginas: 565-567
Archivo PDF: 69.54 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. D’Amico E, Paroli M, Fratelli V, Palazzi C, Barnaba V, Callea F, Consoli G. Primary biliary cirrhosis induced by interferon- alpha therapy for hepatitis C virus infection. Dig Dis Sci 1995: 40: 2113-6.

  2. García-Buey L, García-Monzón C, Rodriguez S, Borque MJ, García-Sánchez A, Iglesias R, DeCastro M, et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 1995: 108: 1770-7.

  3. Imagawa A, Itoh N, Hanafusa T, Oda Y, Waguri M, Miyagawa J, Kono N, et al. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis. J Clin Endocrinol Metab 1995: 80: 922-6. doi: 10.1210/jcem.80.3.7883851.

  4. Lorke J, Erhardt A, Haussinger D. Induction of autoimmune hepatitis by pegylated interferon alfa-2b in chronic hepatitis C. Clin Gastroenterol Hepatol 2004: 2: xx.

  5. Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Hepatogastroenterology 1997; 44: 417-25.

  6. Grimbert S, Johanet C, Bendjaballah F, Homberg JC, Poupon R, Beaugrand M. Antimitochondrial antibodies in patients with chronic hepatitis C. Liver 1996; 16: 161-5.

  7. Tilg H. New insights into the mechanisms of interferon alfa: an immunoregulatory and anti-inflammatory cytokine. Gastroenterology 1997; 112: 1017-21.

  8. Rostaing L, Oksman F, Izopet J, Baron E, Cisterne JM, Hoff M, Abbal M, et al. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C. Am J Nephrol 1996; 16: 478-83.

  9. Mauss S, Berger F, Schober A, Moog G, Heyne R, John C, Pape S, et al. Screening for autoantibodies in chronic hepatitis C patients has no effect on treatment initiation or outcome. J Viral Hepat 2013; 20: e72-7.




2020     |     www.medigraphic.com